PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
42.52K
Worse than AFMD's estimated revenue of 1.79M.
-8.50K
Better than AFMD's estimated ebitda of -1.79M.
-1.41
Better than AFMD's estimated eps of -4.06.
-41.31M
Better than AFMD's estimated net income of -60.59M.
-8.50K
Better than AFMD's estimated ebit of -1.79M.
1.58M
Better than AFMD's estimated sg&a expense of 1.90M.
Analyze DCF forecasts for the company and compare them with competitors.
1.03M
Worse than AFMD's revenue of 46.81M.
-9.97%
Worse than AFMD's revenue growth rate of 2.45%.
-33.41M
Better than AFMD's ebitda of -92.22M.
-3243.20%
Worse than AFMD's ebitda margin of -197.02%.
-34.10M
Better than AFMD's ebit of -95.44M.
-3311.07%
Worse than AFMD's ebit margin of -203.90%.
699.00K
Better than AFMD's depreciation of 3.22M.
108.91M
Worse than AFMD's total cash of 215.38M.
10573.79%
Better than AFMD's cash as percentage of revenue of 460.15%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
10.13M
Better than AFMD's accounts payable of 21.59M.
983.50%
Worse than AFMD's payables as percentage of revenue of 46.13%.
-366.00K
Worse than AFMD's capital expenditure of -787.78K.
-35.53%
Better than AFMD's capex as percentage of revenue of -1.68%.
4.99%
Better than AFMD's weighted average cost of capital (wacc) of 10.05%.
5.02%
Better than AFMD's cost of equity of 13.84%.
4.08%
Better than AFMD's cost of debt of 9.33%.
-0.23
Better than AFMD's beta of 2.07.
30.07M
Worse than AFMD's diluted shares outstanding of 14.94M.
1.57M
Better than AFMD's total debt of 21.90M.
49.31M
Better than AFMD's total equity of 4.17M.
50.89M
Better than AFMD's total capital of 26.07M.
3.09%
Better than AFMD's debt weighting of 84.01%.
96.91%
Better than AFMD's equity weighting of 15.99%.
-32.98M
Better than AFMD's ebiat of -95.44M.
-28.05M
Better than AFMD's unlevered free cash flow of -90.60M.
2.00%
Equal to AFMD's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than AFMD's net debt of -21.71M.
71.33M
Better than AFMD's equity value of -100.35M.
2.37
Better than AFMD's equity value per share of -6.72.